PSY75 - Cost-Effectiveness of Adding Novel or Group 5 Interventions To A Background Regimen For The Treatment of Multidrug-Resistant Tuberculosis In Germany. - Wirth, D; Dass, R; Hettle, R (Value in Health, 2016)